Kolexia
Bonadona Valerie
Santé publique
Centre Léon-Bérard
Lyon, France
90 Activités
2 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Prédisposition génétique à une maladie Tumeurs du sein Tumeurs de l'ovaire Tumeurs hématologiques Tumeurs colorectales Carcinomes Tumeurs colorectales héréditaires sans polypose Syndrome héréditaire de cancer du sein et de l'ovaire Syndrome de Li-Fraumeni

Industries

AstraZeneca
2 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort.
Cancers   29 juin 2023
First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.
European journal of cancer (Oxford, England : 1990)   13 novembre 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial.
Journal of personalized medicine   27 septembre 2022
First estimates of diffuse gastric cancer risks for carriers of germline pathogenic variants.
Journal of medical genetics   29 août 2022
Identification and Characterization of New Element Insertion in the Exon 14 Associated with Hereditary Breast and Ovarian Cancer.
Genes   29 octobre 2021
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
American journal of human genetics   30 septembre 2021
Immune checkpoint inhibitor sensitivity of DNA repair deficient tumors.
Immunotherapy   08 septembre 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Breast cancer research : BCR   03 août 2021
Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.
Breast (Edinburgh, Scotland)   12 juillet 2021